Key terms

About CELC

Celcuity, Inc. is cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. Its proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CELC news

Apr 12 6:07am ET Celcuity: A Promising Buy in Healthcare Innovation and Personalized Oncology Solutions by TipRanks Apr 03 12:06am ET Celcuity (NASDAQ:CELC): A Biotech with Game-Changing Blockbuster Potential by TipRanks Mar 29 2:01am ET Celcuity Inc.’s Balancing Act: Navigating Financial Risks in Capital Raising Endeavors by TipRanks Mar 28 9:10am ET Analysts Are Bullish on These Healthcare Stocks: Trulieve Cannabis (TCNNF), Xtant Medical Holdings (XTNT) by TipRanks Mar 28 9:04am ET Celcuity price target raised to $25 from $20 at Craig-Hallum by TipRanks Mar 28 8:15am ET Gedatolisib’s Promising Clinical Trial Performance and Market Potential Justify Buy Rating by TipRanks Mar 28 6:55am ET Stifel Nicolaus Reaffirms Their Buy Rating on Celcuity (CELC) by TipRanks Mar 28 6:21am ET Analysts Offer Insights on Healthcare Companies: Celcuity (CELC) and Erasca (ERAS) by TipRanks Mar 28 6:00am ET Analysts Are Bullish on These Healthcare Stocks: Celcuity (CELC), Cara Therapeutics (CARA) by TipRanks Mar 27 4:05pm ET Celcuity reports Q4 adjusted EPS (61c), consensus (73c) by TipRanks Feb 23 9:03am ET Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND) and Celcuity (CELC) by TipRanks Feb 22 4:08pm ET Celcuity announces first patient dosed in Phase 1b/2 CELC-G-201 clinical trial by TipRanks Feb 22 9:51am ET DoorDash upgraded, Wendy’s downgraded: Wall Street’s top analyst calls by TipRanks Feb 21 4:10pm ET Celcuity initiated with a Buy at Stifel by TipRanks Feb 20 7:15am ET Celcuity appoints Mayer as Chief Commercial Officer by TipRanks

No recent press releases are available for CELC

CELC Financials

1-year income & revenue

Key terms

CELC Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CELC Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments